Programmed death‐ligand 1 (PD‐L1) expression in pleomorphic carcinoma of the lung

Background and Objectives Pulmonary pleomorphic carcinoma (PPC) is a rare and aggressive subtype of lung cancer. Programmed cell death‐ligand 1 (PD‐L1) expression may be induced in a variety of malignant tumors, but its prognostic implication in PPC remains unclear. Methods Twenty‐six patients with...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of surgical oncology 2018-06, Vol.117 (7), p.1563-1569
Hauptverfasser:	Imanishi, Naoko, Hirai, Ayako, Yoneda, Kazue, Shimajiri, Shohei, Kuwata, Taiji, Tashima, Yuko, Takeuchi, Masahiro, Iwai, Yoshiko, Ichiki, Yoshinobu, Tanaka, Fumihiro
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenoma, Pleomorphic - metabolism Adenoma, Pleomorphic - pathology Adenoma, Pleomorphic - surgery Adult Aged Aged, 80 and over B7-H1 Antigen - metabolism Biomarkers, Tumor - metabolism Cancer Cancer surgery Carcinoma, Non-Small-Cell Lung - metabolism Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Non-Small-Cell Lung - surgery Female Follow-Up Studies Gene Expression Regulation, Neoplastic Humans Ligands Lung cancer Lung Neoplasms - metabolism Lung Neoplasms - pathology Lung Neoplasms - surgery Male Medical prognosis Middle Aged PD‐L1 Prognosis pulmonary pleomorphic carcinoma Retrospective Studies Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!